Utilizing CIWA-Ar to assess use of benzodiazepines in patients vulnerable to alcohol withdrawal syndrome.

Michelle Ann Nuss, D. Michael Elnicki, Teresa S. Dunsworth, Eugene H. Makela

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

To determine whether use of the revised Clinical Institute Withdrawal Assessment (CIWA-Ar) would better guide treatment for the Alcohol Withdrawal Syndrome (AWS), we prospectively studied 16 patients identified as alcohol dependent or with a positive blood alcohol level on admission. All patients were administered the CIWA-Ar. If it was > or = 10, the patient was randomized to a benzodiazepine. If the CIWA-Ar was < 10, the patient was observed and the CIWA-Ar was administered every eight hours for 48 hours. Of the 35 patients screened, 16 were enrolled. Seven patients had a score of > or = 10 and entered a benzodiazepine treatment program. The mean CIWA-Ar score was 18 +/- 10. The remaining nine patients had an initial CIWA-Ar < 10, with a mean score of 3.8 +/- 2.4. We safely withheld detoxification regimens in 9 of 16 patients based on CIWA-Ar scores. The CIWA-Ar may obviate over-utilization of benzodiazepines in patients with AWS.

Original languageEnglish (US)
Pages (from-to)21-25
Number of pages5
JournalThe West Virginia medical journal
Volume100
Issue number1
StatePublished - Jan 1 2004

Fingerprint

Benzodiazepines
Alcohols
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Utilizing CIWA-Ar to assess use of benzodiazepines in patients vulnerable to alcohol withdrawal syndrome. / Nuss, Michelle Ann; Elnicki, D. Michael; Dunsworth, Teresa S.; Makela, Eugene H.

In: The West Virginia medical journal, Vol. 100, No. 1, 01.01.2004, p. 21-25.

Research output: Contribution to journalArticle

Nuss, Michelle Ann ; Elnicki, D. Michael ; Dunsworth, Teresa S. ; Makela, Eugene H. / Utilizing CIWA-Ar to assess use of benzodiazepines in patients vulnerable to alcohol withdrawal syndrome. In: The West Virginia medical journal. 2004 ; Vol. 100, No. 1. pp. 21-25.
@article{498956f56f6e4f339746193430dca7fd,
title = "Utilizing CIWA-Ar to assess use of benzodiazepines in patients vulnerable to alcohol withdrawal syndrome.",
abstract = "To determine whether use of the revised Clinical Institute Withdrawal Assessment (CIWA-Ar) would better guide treatment for the Alcohol Withdrawal Syndrome (AWS), we prospectively studied 16 patients identified as alcohol dependent or with a positive blood alcohol level on admission. All patients were administered the CIWA-Ar. If it was > or = 10, the patient was randomized to a benzodiazepine. If the CIWA-Ar was < 10, the patient was observed and the CIWA-Ar was administered every eight hours for 48 hours. Of the 35 patients screened, 16 were enrolled. Seven patients had a score of > or = 10 and entered a benzodiazepine treatment program. The mean CIWA-Ar score was 18 +/- 10. The remaining nine patients had an initial CIWA-Ar < 10, with a mean score of 3.8 +/- 2.4. We safely withheld detoxification regimens in 9 of 16 patients based on CIWA-Ar scores. The CIWA-Ar may obviate over-utilization of benzodiazepines in patients with AWS.",
author = "Nuss, {Michelle Ann} and Elnicki, {D. Michael} and Dunsworth, {Teresa S.} and Makela, {Eugene H.}",
year = "2004",
month = "1",
day = "1",
language = "English (US)",
volume = "100",
pages = "21--25",
journal = "West Virginia Medical Journal",
issn = "0043-3284",
publisher = "West Virginia State Medical Association",
number = "1",

}

TY - JOUR

T1 - Utilizing CIWA-Ar to assess use of benzodiazepines in patients vulnerable to alcohol withdrawal syndrome.

AU - Nuss, Michelle Ann

AU - Elnicki, D. Michael

AU - Dunsworth, Teresa S.

AU - Makela, Eugene H.

PY - 2004/1/1

Y1 - 2004/1/1

N2 - To determine whether use of the revised Clinical Institute Withdrawal Assessment (CIWA-Ar) would better guide treatment for the Alcohol Withdrawal Syndrome (AWS), we prospectively studied 16 patients identified as alcohol dependent or with a positive blood alcohol level on admission. All patients were administered the CIWA-Ar. If it was > or = 10, the patient was randomized to a benzodiazepine. If the CIWA-Ar was < 10, the patient was observed and the CIWA-Ar was administered every eight hours for 48 hours. Of the 35 patients screened, 16 were enrolled. Seven patients had a score of > or = 10 and entered a benzodiazepine treatment program. The mean CIWA-Ar score was 18 +/- 10. The remaining nine patients had an initial CIWA-Ar < 10, with a mean score of 3.8 +/- 2.4. We safely withheld detoxification regimens in 9 of 16 patients based on CIWA-Ar scores. The CIWA-Ar may obviate over-utilization of benzodiazepines in patients with AWS.

AB - To determine whether use of the revised Clinical Institute Withdrawal Assessment (CIWA-Ar) would better guide treatment for the Alcohol Withdrawal Syndrome (AWS), we prospectively studied 16 patients identified as alcohol dependent or with a positive blood alcohol level on admission. All patients were administered the CIWA-Ar. If it was > or = 10, the patient was randomized to a benzodiazepine. If the CIWA-Ar was < 10, the patient was observed and the CIWA-Ar was administered every eight hours for 48 hours. Of the 35 patients screened, 16 were enrolled. Seven patients had a score of > or = 10 and entered a benzodiazepine treatment program. The mean CIWA-Ar score was 18 +/- 10. The remaining nine patients had an initial CIWA-Ar < 10, with a mean score of 3.8 +/- 2.4. We safely withheld detoxification regimens in 9 of 16 patients based on CIWA-Ar scores. The CIWA-Ar may obviate over-utilization of benzodiazepines in patients with AWS.

UR - http://www.scopus.com/inward/record.url?scp=2542483848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2542483848&partnerID=8YFLogxK

M3 - Article

C2 - 15119493

AN - SCOPUS:2542483848

VL - 100

SP - 21

EP - 25

JO - West Virginia Medical Journal

JF - West Virginia Medical Journal

SN - 0043-3284

IS - 1

ER -